ESSA Pharma Inc (EPIX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart
Ticker: EPIX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-05 2024-11-01 S Sale

BIOTECH GROWTH N V

Large shareholder
1,879,583 -100.0%
1.51
USD 2,843,809 		1,879,583 -100.0% 1.51 USD 2,843,809
2024-11-05 2024-11-01 S Sale

BIOTECH GROWTH N V

Large shareholder
2,000,000 -51.6%
1.53
USD 3,058,800 		2,000,000 -51.6% 1.53 USD 3,058,800
2024-11-05 2024-11-01 S Sale

BIOTECH GROWTH N V

Large shareholder
2,000,000 -34.0%
1.53
USD 3,051,800 		2,000,000 -34.0% 1.53 USD 3,051,800
2024-11-05 2024-11-01 S Sale

BIOTECH GROWTH N V

Large shareholder
2,000,000 -25.4%
1.53
USD 3,064,000 		2,000,000 -25.4% 1.53 USD 3,064,000
2024-10-07 2024-10-07 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
694 -8.2%
6.03
USD 4,185 		694 -8.2% 6.03 USD 4,185
2024-10-07 2024-10-07 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -8.2%
6.03
USD 4,185 		694 -8.2% 6.03 USD 4,185
2024-09-09 2024-09-09 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
694 -7.6%
6.00
USD 4,164 		694 -7.6% 6.00 USD 4,164
2024-09-09 2024-09-09 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -7.6%
6.00
USD 4,164 		694 -7.6% 6.00 USD 4,164
2024-09-03 2024-09-03 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
2,082 -18.5%
6.03
USD 12,554 		2,082 -18.5% 6.03 USD 12,554
2024-09-03 2024-09-03 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
2,082 -18.5%
6.03
USD 12,554 		2,082 -18.5% 6.03 USD 12,554
2024-05-06 2024-05-06 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -5.8%
6.95
USD 4,823 		694 -5.8% 6.95 USD 4,823
2024-04-05 2024-04-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -5.5%
7.94
USD 5,510 		694 -5.5% 7.94 USD 5,510
2024-04-05 2024-04-05 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
694 -5.5%
7.94
USD 5,510 		694 -5.5% 7.94 USD 5,510
2024-03-05 2024-03-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -5.2%
8.98
USD 6,232 		694 -5.2% 8.98 USD 6,232
2024-02-07 2024-02-06 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
72,782 -84.5%
10.29
USD 748,927 		72,782 -84.5% 10.29 USD 748,927
2024-02-06 2024-02-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
500 -3.6%
10.04
USD 5,020 		500 -3.6% 10.04 USD 5,020
2024-02-06 2024-02-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
694 -4.9%
9.25
USD 6,420 		694 -4.9% 9.25 USD 6,420
2024-01-17 2024-01-16 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
1,718 -10.9%
10.01
USD 17,197 		1,718 -10.9% 10.01 USD 17,197
2024-01-11 2024-01-05 PS Planned sale

Virsik, Peter

Director of Issuer

Non-Executive Director
699 -4.7%
6.11
USD 4,271 		699 -4.7% 6.11 USD 4,271
2024-01-08 2024-01-05 PS Planned sale

Virsik Peter

Chief Operating Officer

Officer
699 -4.7%
6.11
USD 4,271 		699 -4.7% 6.11 USD 4,271
2023-12-18 2023-12-14 B Purchase

Parkinson, David

Director of Issuer

Non-Executive Director
9,223 +16.3%
2.30
USD 21,250 		9,223 +16.3% 2.30 USD 21,250
2023-12-18 2023-12-14 PP Planned purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
9,223 +16.3%
2.30
USD 21,213 		9,223 +16.3% 2.30 USD 21,213
2023-11-22 2023-11-21 B Purchase

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
23,529 +3.1%
5.73
USD 134,821 		23,529 +3.1% 5.73 USD 134,821
2023-11-22 2023-11-21 B Purchase

BERGER FRANKLIN M

Non-Executive Director
23,259 +3.1%
5.73
USD 133,274 		23,259 +3.1% 5.73 USD 133,274
2023-11-16 2023-11-03 B Purchase

BERGER FRANKLIN M

Non-Executive Director
16,471 +2.2%
5.99
USD 98,661 		16,471 +2.2% 5.99 USD 98,661
2023-11-16 2023-11-02 B Purchase

BERGER FRANKLIN M

Non-Executive Director
60,000 +8.8%
5.35
USD 321,000 		60,000 +8.8% 5.35 USD 321,000
2023-01-05 2022-12-30 PP Planned purchase

Wood, David Sidney

Senior Officer of Issuer

Officer
8,302 +33.2%
2.60
USD 21,585 		8,302 +33.2% 2.60 USD 21,585
2023-01-05 2022-12-30 PP Planned purchase

Parkinson, David

Director of Issuer

Non-Executive Director
3,067 +5.7%
2.60
USD 7,974 		3,067 +5.7% 2.60 USD 7,974
2023-01-05 2022-12-30 PP Planned purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
3,067 +5.7%
2.60
USD 7,974 		3,067 +5.7% 2.60 USD 7,974
2023-01-05 2022-12-30 PP Planned purchase

Wood David S.

Chief Financial Officer

Officer
8,302 +33.2%
2.60
USD 21,585 		8,302 +33.2% 2.60 USD 21,585
2023-01-05 2022-12-22 B Purchase

Parkinson, David

Director of Issuer

Non-Executive Director
21,367 +66.5%
2.39
USD 51,067 		21,367 +66.5% 2.39 USD 51,067
2023-01-05 2022-12-22 B Purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
21,367 +66.5%
2.39
USD 51,067 		21,367 +66.5% 2.39 USD 51,067
2023-01-05 2022-12-21 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
34,334 -4.8%
2.42
USD 83,088 		34,334 -4.8% 2.42 USD 83,088
2023-01-05 2022-12-21 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
37,889 -5.0%
2.41
USD 91,312 		37,889 -5.0% 2.41 USD 91,312
2023-01-05 2022-12-21 S Sale

BERGER FRANKLIN M

Non-Executive Director
34,334 -4.8%
2.42
USD 83,088 		34,334 -4.8% 2.42 USD 83,088
2023-01-05 2022-12-21 S Sale

BERGER FRANKLIN M

Non-Executive Director
37,889 -5.0%
2.41
USD 91,312 		37,889 -5.0% 2.41 USD 91,312
2023-01-05 2022-12-20 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
43,617 -5.5%
2.53
USD 110,351 		43,617 -5.5% 2.53 USD 110,351
2023-01-05 2022-12-20 S Sale

BERGER FRANKLIN M

Non-Executive Director
43,617 -5.5%
2.53
USD 110,351 		43,617 -5.5% 2.53 USD 110,351
2023-01-05 2022-12-16 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.9%
2.67
USD 133,500 		50,000 -5.9% 2.67 USD 133,500
2023-01-05 2022-12-16 S Sale

BERGER FRANKLIN M

Non-Executive Director
50,000 -5.9%
2.67
USD 133,500 		50,000 -5.9% 2.67 USD 133,500
2023-01-05 2022-12-15 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
50,000 -5.6%
2.86
USD 143,000 		50,000 -5.6% 2.86 USD 143,000
2023-01-05 2022-12-15 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
32,000 -3.4%
2.90
USD 92,800 		32,000 -3.4% 2.90 USD 92,800
2023-01-05 2022-12-15 S Sale

BERGER FRANKLIN M

Non-Executive Director
50,000 -5.6%
2.86
USD 143,000 		50,000 -5.6% 2.86 USD 143,000
2023-01-05 2022-12-15 S Sale

BERGER FRANKLIN M

Non-Executive Director
32,000 -3.4%
2.90
USD 92,800 		32,000 -3.4% 2.90 USD 92,800
2023-01-05 2022-12-14 S Sale

BERGER, FRANKLIN MILAN

Director of Issuer

Non-Executive Director
25,000 -2.6%
3.00
USD 75,000 		25,000 -2.6% 3.00 USD 75,000
2023-01-05 2022-12-14 S Sale

BERGER FRANKLIN M

Non-Executive Director
25,000 -2.6%
3.00
USD 75,000 		25,000 -2.6% 3.00 USD 75,000
2022-10-28 2022-10-27 B Purchase

BIOTECH GROWTH N V

Large shareholder
500,000 +6.8%
4.50
USD 2,251,100 		500,000 +6.8% 4.50 USD 2,251,100
2022-10-28 2022-10-26 B Purchase

BIOTECH GROWTH N V

Large shareholder
1,500,000 +25.5%
3.98
USD 5,968,500 		1,500,000 +25.5% 3.98 USD 5,968,500
2022-07-20 2022-07-18 B Purchase

BIOTECH GROWTH N V

Large shareholder
300,000 +5.4%
3.16
USD 946,740 		300,000 +5.4% 3.16 USD 946,740
2022-07-18 2022-07-15 B Purchase

BIOTECH GROWTH N V

Large shareholder
241,665 +4.5%
3.13
USD 756,798 		241,665 +4.5% 3.13 USD 756,798
2022-07-18 2022-07-14 B Purchase

BIOTECH GROWTH N V

Large shareholder
347,204 +7.0%
2.79
USD 969,428 		347,204 +7.0% 2.79 USD 969,428
2022-07-05 2022-06-30 B Purchase

Parkinson David Ross

Chief Executive Officer

Executive Director
4,887 +18.0%
2.96
USD 14,456 		4,887 +18.0% 2.96 USD 14,456
2022-04-28 2022-04-27 S Sale

BIOTECH GROWTH N V

Large shareholder
25,100 -0.5%
5.85
USD 146,925 		25,100 -0.5% 5.85 USD 146,925
2021-03-04 2021-02-22 B Purchase

BERGER FRANKLIN M

Non-Executive Director
57,000 +6.3%
27.00
USD 1,539,000 		57,000 +6.3% 27.00 USD 1,539,000
// ... existing code ... // ... rest of the file ...